| For: | Mohammadi S, Al-Harrasi A. Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy? World J Diabetes 2024; 15(9): 1847-1852 [PMID: 39280186 DOI: 10.4239/wjd.v15.i9.1847] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i9/1847.htm |
| Number | Citing Articles |
| 1 |
Shan Li, Yuhe Shu, Shuyu Yang, Simin Zhang, Haoling Chen, Dan Wu, Bo Li, Li Dong. Oxidative stress and ferroptosis in diabetic cardiomyopathy: mechanistic interplay and therapeutic implications. Apoptosis 2025; 30(11-12) doi: 10.1007/s10495-025-02170-5
|
| 2 |
Jingyi Lv, Xiaoyi Bao, Xiaolu Jiao, Yue Jiang, Maoning Lin, Wenbin Zhang, Min Wang. Diabetic cardiomyopathy: Target immune cell from mechanism to treatment. International Immunopharmacology 2026; 186 doi: 10.1016/j.intimp.2026.117116
|
| 3 |
Bin Liu, Qing Jin, Yi Kang Sun, Zhi Ming Yang, Ping Meng, Xi Zhang, Qiu Chen, Pin Gan, Tao Zhao, Jia Ji He, Gui Ping He, Qiang Xue. From bench to bedside: targeting ferroptosis and mitochondrial damage in the treatment of diabetic cardiomyopathy. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1563362
|
| 4 |
Snehal Raut, Luca Cucullo. Antidiabetic Agents as Antioxidant and Anti-Inflammatory Therapies in Neurological and Cardiovascular Diseases. Antioxidants 2025; 14(12) doi: 10.3390/antiox14121490
|